The Federal government has been charged to prioritise support for local pharmaceutical companies by promoting and enabling the local pharmaceutical manufacturing industry in Nigeria.
Active Pharmaceutical Ingredients are active components that give pharmaceutical drugs their therapeutic effect. The quality, purity, and stability of APIs can significantly impact the safety and efficacy of the final drug products. Okoli, whose company started local production of pharmaceuticals four decades ago said, “Government has a lot to do in supporting local manufacturers. It is a fact that the prosperity of the nation resides with local production. This is how the dwindling economy can be successfully revived. As a company, we are playing our part and we shall continue to do so.
Arthur Delor, the Investment Officer, Project Finance Division, Corporate Finance and Global Activities Department of the European Investment Bank, EIB, which has established a special fund for the growth of API manufacturing in Africa, described the API Project by Emzor as a new dawn in development and growth of Africa’s pharmaceutical industry.
“Africa as a place should start to contribute to global development, not just to depend on others and our choice of Emzor is very appropriate to pioneer this project in Africa. Emzor is well established and well positioned to make Africa, especially Nigeria a hub of quality products and supply chain.